Die Information für Ärzte und Apotheker
Neutral, unabhängig und anzeigenfrei
arznei-telegramm® 02/2016
previous issue next issue
This is a translation of the table of contents. One article is translated and freely available.

REVIEW
On the benefit of standard vaccines: tetanus

NEW ON THE MARKET
Idarucizumab (PRAXBIND): antidote for dabigatran

a-t READER'S QUESTIONS AND COMMENTS
Red yeast rice: withdrawal of products from the market is overdue
Is it allowed to substitute immediate-release preparations for prolonged-release preparations?

IN BRIEF
Rivaroxaban (XARELTO) rehabilitated?
Betahistine (e.g. VASOMOTAL) for MENIÈRE´s disease
Fusafungine (LOCABIOSOL): withdrawal from the market recommended
Misleading trade names of painkillers
Error analysis: BIA 10-2474 in phase 1 testing

CURRENT ADR NETWORK REPORT
Urinary incontinence due to safinamide (XADAGO)?  free article 

SIDE EFFECTS

e a-t IN THE INTERNET
Dimethyl fumarate (TECFIDERA): first progressive multifocal leukoencephalopathy with only moderate lymphopenia
© 2020 arznei-telegramm